Skip to content

Exploring the role of thrombophilias in women with recurrent pregnancy loss and its treatment

The role of low-molecular-weight-heparin in women with recurrent pregnancy loss and protein S deficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN64574169
Enrollment
60
Registered
2016-07-19
Start date
2016-02-16
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent miscarriage Pregnancy and Childbirth

Interventions

Part 1: Women who had recurrent pregnancy loss (RPL) who have been prescribed heparin between 2011 and 2015 as part of their standard medical care have their medical notes reviewed. La

Sponsors

Changhua Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Part 1: 1. Women of child-bearing age 2. Recurrent pregnancy loss 3. Treated with heparin as part of standard care between 2011 and 2015 Part 2: 1. Women of child-bearing age 2. Recurrent pregnancy loss 3. Protein S deficiency (both the free antigen and function of protein S were reduced)

Exclusion criteria

Exclusion criteria: 1. Allergic to heparin or other Low Molecular Weight Heparins 2. Problem with bruising or bleeding too easily 3. History of heparin-induced thrombocytopenia 4. Stroke 5. Recently had an operation on brain 6. Renal dysfunction

Design outcomes

Primary

MeasureTime frame
Live birth rate is measured using the outcome of pregnancy at either abortion or live-births at the time of delivery collected from medical records.

Secondary

MeasureTime frame
Obstetric complication rate is measured using specific parameters such as the birth body weight (if it is low birth weight for gestational age, or appropriate for gestational age), the gestational age when delivery (if less than 28 weeks, between 28 and 36 weeks of gestation, or term pregnancy meaning delivered later than 36 complete weeks of gestation) at delivery collected from medical records.

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 11, 2026